The following discussion of our financial condition and results of operations
should be read in conjunction with our Consolidated Financial Statements and
related notes in Part II, Item 8. Financial Statements and Supplementary Data of
this 2019 Form 10-K.

Overview

Incorporated in 1989, Stericycle protects people, safeguards communities, and
reduces risk through highly specialized medical and hazardous waste management
and secure information services. Our team of more than 19,500 employees serves
customers in the U.S. and 18 other countries with a concentration on the growing
healthcare industry. We are a world-leading services company with the scale,
expertise, and experience to handle complicated and behind-the-scenes essential
services for waste management, regulatory compliance and destruction of secure
information. To our customers, team members and the communities we serve,
Stericycle is a company that protects what matters.

Our offering of services appeals to a wide range of small and large business
customers. The majority of our customers are healthcare businesses (hospitals,
physician, and dental practices, outpatient clinics, long-term care facilities,
etc.). We also provide services to retailers, manufacturers, financial services
providers, professional services providers, governmental entities, and other
businesses. While we manage large volumes of waste and other materials, the
volume per customer site on average is small.

Highlights for the year ended December 31, 2019 compared to the prior year include:

• Revenues for the year ended December 31, 2019 were $3.31 billion, compared

to $3.49 billion in 2018. The decline of $177.0 million was due to the

impact of divestitures and macroeconomic factors of foreign exchange rates

and SOP pricing which reduced revenues by $64.1 million, $67.8 million and

$41.5 million, respectively.

• Organic revenue in RWCS and SID, excluding the impact of SOP pricing,

remained strong with increases of 0.7% and 3.6% compared to 2018,

respectively. These were more than offset by continued lowered sales in


        Domestic CRS primarily due to smaller sized recall events and fewer
        mandated recalls and lower M&I revenues.

• Loss from operations for the year was $211.9 million in 2019, compared to

loss from operations of $161.1 million in 2018. We incurred significant

charges associated with key priorities and other significant matters of

$663.9 million and $780.1 million as detailed below in 2019 and 2018,

respectively. Excluding these matters, loss from operations decreased by

$167.0 million which is attributed to macroeconomic factors of $59.0

million including SOP Pricing and foreign exchange, the impact of

divestitures, and operational matters of $108.0 million including higher

RWCS and corporate operating costs and declines in CRS operations.

• Net loss was $346.8 million, or $3.81 diluted loss per share, compared

with $253.3 million, or $2.91 diluted loss per share, in 2018, primarily

due to the changes in significant charges associated with key priorities


        and other significant matters and operational items previously
        highlighted.

• Cash flow from operations for the full year was $248.0 million, compared

to $165.7 million for 2018. In 2018, cash flow from operations was reduced

by the Small Quantity customer class action settlement payment of $295.0

million. Excluding the settlement payment, cash flow from operations

decreased $212.7 million, primarily due to lower operating performance in


        2019, as



2019 10-K Annual Report Stericycle, Inc. • 36


--------------------------------------------------------------------------------

PART II

previously highlighted, and payments in 2019 for certain litigation

matters, 2018 incentive compensation and ERP-related prepaid software.

• Capital expenditures for the year were $194.2 million, including $80.6

million for the ERP implementation, compared to $130.8 million in 2018,

including $18.0 million for the ERP implementation.

During 2019, we completed the following debt related transactions:

a) Issued $600.0 million at par of aggregate principal Senior Notes, due July

2024, which are unsecured and bear interest at 5.375% per annum, payable

on January 15 and July 15 of each year.

b) Executed the Fourth Amendment which amended the Credit Agreement to, among

other things, (i) provide an incremental Term Loan of $365.0 million, (ii)

modify the definition of "Consolidated EBITDA", (iii) revise the financial

covenant requirement for our Consolidated Leverage Ratio and (iv) make

certain other modifications to negative covenants related to restricted


        payments and investments that we may make.


    c)  Repaid in full $1.075 billion of the outstanding private placement notes

using the net proceeds from the Senior Notes and the incremental Term Loan

together with additional borrowings under the Senior Credit Facility.

On February 25, 2020, we executed the Fifth Amendment which amended the Credit Agreement to, among other things:

• increase the maximum allowable Consolidated Leverage Ratio to 5.00 to 1.00

until the end of the first quarter of 2022 and 4.50 to 1.00 thereafter.

• upon the consummation of the divesture of the ESOL Disposal Group, each of


        the foregoing maximum permitted Consolidated Leverage Ratio levels will
        step down to 4.75 to 1.00 and 4.25 to 1.00, respectively.

• allow for continuation of the $200 million of cash add backs to EBITDA

through December 31, 2020, and addbacks of $100 million until December 31,

2021, with no further addbacks thereafter.

• increase the leverage ratio pricing tier of greater than 4.50 to 1.00 by

0.125%.

• grant a first-priority security interest to the administrative agent for

the benefit of the lenders in substantially all of the personal property

of the Company and certain of its material domestic subsidiaries,

including certain equity interests held by those entities.

For additional information, see Part II, Item 8, Financial Statements and Supplementary Data; Note 9 - Debt in the Consolidated Financial Statements.



Over the course of 2019, we divested a texting business based in the UK, a
telephone answering services business and pharmaceutical returns business in
North America, and substantially all of our operations in Mexico and Chile. The
five transactions combined generated $83.7 million in gross proceeds during
2019.

As a result of these divestitures we recorded total non-cash divestiture losses,
net of gains, of $103.0 million. (For additional information, see Part II, Item
8, Financial Statements and Supplementary Data; Note 4 - Restructuring and
Divestitures in the Consolidated Financial Statements).

On February 6, 2020, we entered into the Purchase Agreement to sell our Domestic Environmental Solutions business to Harsco Corporation, exclusive of the Retained Business.

2019 10-K Annual Report Stericycle, Inc. • 37


--------------------------------------------------------------------------------

PART II



Subject to the terms and conditions of the Purchase Agreement, the Buyer has
agreed to purchase all of the outstanding equity interests of our Domestic
Environmental Solutions subsidiary. Both we and Buyer have agreed to indemnify
the other party for losses arising from certain breaches of the Purchase
Agreement and other liabilities, subject to certain limitations.

The purchase price for the Transaction is approximately $462.5 million, and
subject to adjustment based on the ESOL Disposal Group's net working capital at
closing and other adjustments as defined in the Purchase Agreement. The
Transaction is anticipated to result in a loss which is currently not estimable.
The expected charge is based on our current estimate of the proceeds that will
be allocated to the disposal transaction as we evaluate the terms of the HSA
agreement negotiated with the Buyer concurrently with the Transaction, the net
assets that will be disposed of and an allocation of goodwill based on the
relative fair value of the ESOL Disposal Group to the Domestic Environmental
Solutions reporting unit. The remaining goodwill will be allocated to the
Retained Business which we anticipate will become part of the Domestic
Healthcare Compliance Services reporting unit once the transaction closes.

The Purchase Agreement contains customary representations, warranties and
covenants related to the Business and the Transaction. Between the date of the
Purchase Agreement and the completion of the Transaction, we have agreed to
conduct the ordinary course of the ESOL Disposal Group business consistent with
past practices in all material respects and have agreed to certain other
operating covenants with respect to the ESOL Disposal Group business as set
forth more fully in the Purchase Agreement. The Purchase Agreement includes
customary termination provisions, including if the closing of the Transaction
has not occurred on or before November 6, 2020 (which may be extended until
February 6, 2021, if needed, to obtain applicable regulatory approvals). Both we
and the Buyer have agreed to indemnify the other party for losses arising from
certain breaches of the Purchase Agreement and other liabilities, subject to
certain limitations.

In connection with the closing of the Transaction, we and Buyer will enter into
certain additional ancillary agreements, including a transition services
agreement. We and Buyer will also enter into a long-term subcontracted HSA with
respect to our Retained Business. We currently provide integrated waste
compliance services to healthcare customers, including medical and hazardous
waste disposal services. We will continue to be the integrated waste services
provider to these customers and have subcontracted with the Buyer to performed
hazardous waste services, including collection, transportation and disposal as
necessary.

The Domestic Environmental Solutions business generated revenue of $559.6 million, including approximately $100.0 million related to the Retained Business, which is included in the Regulated Waste and Compliance Services revenue category and in the North America RWCS segment.

Key Business Priorities



Following its founding in 1989, Stericycle grew rapidly as the medical waste
industry developed and largely through inorganic acquisitions. Growth from
medical waste acquisitions helped us achieve scale of infrastructure, route
density, and a leadership position in the U.S. We also leveraged acquisitions to
enter new geographies or add additional services to our portfolio. As we grew
and evolved, we operated without centralization and the efficiencies that come
from an integrated, modern corporate structure and associated information
systems.



2019 10-K Annual Report Stericycle, Inc. • 38


--------------------------------------------------------------------------------

PART II

The following table identifies key priorities and other significant matters impacting our business (amounts are stated pre-tax except when noted):





In millions
                                                        Year Ended December 31,
                                                     2019        2018         2017
Pre-tax items:
Included in COR
Business Transformation                             $   0.4     $   8.1     $    0.7
Operational Optimization                                9.8           -          0.4
Asset Impairments                                       5.2        17.6            -
Total included in COR                                  15.4        25.7          1.1

Included in SG&A
Business Transformation                                67.3        74.5         30.6
Intangible Amortization                               145.2       130.3        118.4
Acquisition and Integration                             3.5         9.8         40.7
Operational Optimization                                4.7        29.4         70.7
Divestitures                                           11.7         7.7            -

Litigation, Settlements and Regulatory Compliance 28.2 93.2


   327.7
Asset Impairments                                      16.9         8.9            -
Other                                                  39.7        29.1         24.8
Total included in SG&A                                317.2       382.9        612.9

Divestiture losses, net of gains                      103.0        12.8          9.5

Goodwill impairment                                   228.3       358.7         65.0

Total included in Loss from operations                663.9       780.1     

688.5



Included in Interest expense, net
Capital Allocation (debt related)                       3.6         2.7     

-



Loss on early extinguishment of debt                   23.1           -     

-



Included in Other expense, net
Other (including highly inflationary exchange loss)     3.3         3.8            -
Total pre-tax                                       $ 693.9     $ 786.6     $  688.5

After tax items:
Capital Allocation (preferred dividends)            $     -     $  25.5     $   36.3
U.S. Tax Reform                                           -         8.8       (129.8 )
Total after-tax                                     $     -     $  34.3     $  (93.5 )

2019 10-K Annual Report Stericycle, Inc. • 39


--------------------------------------------------------------------------------

PART II



The above priorities and other significant matters include the following types
of activities:



                                   Cash Charges
                                           Consulting
                Closure and                   and
                    Exit                  Professional                  Non-Cash
                  Costs(1)   Internal (2)     Fees      Other (3)     Charges (4)
Business             ?            ?            ?            ?              ?
Transformation
Acquisition and      ?            ?            ?            ?              ?
Integration
Operational          ?            ?            ?            ?              ?
Optimization
Divestitures                                   ?            ?              ?
Litigation,
Settlements and                                ?            ?
Regulatory
Compliance
Other                                          ?

(1) Includes employee and contract termination, facility closure, and clean-up


        costs.


    (2) Includes dedicated resources, including project related incentive
        compensation and stock-based compensation.

(3) Includes other costs related to each priority e.g. software maintenance

fees, changes in contingent consideration and environmental provisions.

(4) Includes impairments, accelerated depreciation, and/or amortization,

gain/loss on disposal, and changes in deferred consideration.

At the end of 2017, we began implementation of a business transformation, including the development of an ERP system, focused on driving long-term growth, improving profitability, and enhancing shareholder value. During 2019, we refocused our transformation efforts and aligned around five key business priorities.

1. Portfolio rationalization - As we look to the future, we continue to

pursue the divestiture of service lines or geographies that are not

profitable, have limited growth potential, are not vertically integrated,


        are not essential to our regulated waste and compliance services and
        secure information destruction service categories, and/or present the
        opportunity to reduce debt.

2. Quality of revenue - The services we offer help our customers meet complex

regulations. Our expertise, infrastructure and service levels provide a

differentiated and premium brand value to the customers we serve. As such,

we are focused on improving the quality of revenue we deliver. During

2019, we added a Chief Commercial Officer and began implementing changes

in our commercial operations. We realigned our sales organization around


        customer channels; implemented best practices for sales management and
        training; reorganized our marketing teams to focus functional area of
        expertise across services; and improved our contracting processes with
        customers.

3. Operational cost efficiencies - Our day-to-day operations are shifting

toward a standardized operating model to optimize processes, drive

efficiencies and improve both safety and service. During 2019, we added a

Chief Engineer and have begun centralizing operational decision making

under a corporate engineering group. Additionally, we are focused on

driving cost efficiencies through work measurement, asset optimization,


        use of technology, and expanded strategic sourcing.



2019 10-K Annual Report Stericycle, Inc. • 40


--------------------------------------------------------------------------------

PART II

4. Debt reduction and leverage improvement - As a result of the debt


        accumulated from our historic acquisition strategy, debt structure and
        debt improvement were a key focus in 2019. In June 2019, we raised $600
        million from the issuance of our Senior Notes and $365 million from an

incremental Term Loan. Combined with an additional draw from our Senior

Credit Facility, Stericycle paid off its more restrictive $1.075

billion-dollar private placement notes. Additionally, in 2019, we applied

cash flow from operations and proceeds from divestitures to enable a net

debt reduction of approximately $100.0 million.

5. ERP implementation - Over our 30-year history, Stericycle had acquired

more than 500 companies without fully integrating certain acquisitions

onto centralized information technology platforms. The disparate operating

and information systems have resulted in significant operational

inefficiencies. With the implementation of an ERP, we expect to improve

daily decision making via real-time information insights, simplify and

enhance forecast accuracy, provide transparency for greater

accountability, aid in the development of strategic planning, and make it

easier for our customers to do business with us. The "go-live" of the ERP

system began in January 2020 with the global roll-out of the

human-resources performance management module. During 2020, the additional

ERP capabilities, including commercial, operational and financial, will be

implemented in a staged approach across our North America RWCS reportable


        segment, excluding the ESOL Disposal Group.



2019 10-K Annual Report Stericycle, Inc. • 41


--------------------------------------------------------------------------------

                                                                         PART II

Business Transformation

Since the program's inception, we have recognized the following charges and capital expenditures related to the Business Transformation:





In millions
                                           Year Ended December 31,
                                                                                   Cumulative Since
                                   2019              2018             2017            Inception
Investment in Costs Savings
and Business Capability
Exit costs - employee
termination                    $           -     $          -     $        6.7     $            6.7
Consulting and professional
fees                                     0.4             27.1             15.8                 43.3
Internal costs                           2.4              4.4              1.3                  8.1
Other related expenses                   3.3              1.4                -                  4.7
Total                                    6.1             32.9             23.8                 62.8

ERP Development and
Implementation
Consulting and professional
fees                                    27.2             16.0                -                 43.2
Internal costs                           9.3              8.7              0.1                 18.1
Software usage/maintenance
fees                                    15.3              7.4                -                 22.7
Other related expenses                   4.3              0.6              1.0                  5.9
                                        56.1             32.7              1.1                 89.9
Capital expenditures                    80.6             18.0             10.9                109.5
Total                                  136.7             50.7             12.0                199.4

Other Related Matters
Exit costs - employee
termination                              5.5              3.7              4.1                 13.3
Consulting and professional
fees                                       -              4.2                -                  4.2
Non-cash charges                           -              9.1              2.3                 11.4
Total                                    5.5             17.0              6.4                 28.9

Total charges and capital
expenditures                   $       148.3     $      100.6     $       42.2     $          291.1

Non-cash related charges       $         1.8     $        9.4     $        2.4     $           13.6
Cash related charges
(including stock based
compensation)                           65.9             73.2             28.9                168.0

Total operating expenditures $ 67.7 $ 82.6 $ 31.3 $ 181.6




Through December 31, 2019, we have completed activities originally contemplated
as part of Business Transformation in the areas of investment in costs savings
and business capability and other related matters. Prospectively, Business
Transformation activities will be focused on ERP development and implementation
with additional operating expenditures and capital expenditures anticipated in
2020 to complete design, testing and deployment in North America. Once the North
America deployment occurs, additional costs will be added to ongoing operations
to reflect the cost of the ERP post go-live. For 2020, and beyond, we will
continue to incur costs to maintain the legacy suite of applications supporting
our global businesses until those applications are replaced by the new ERP.



2019 10-K Annual Report Stericycle, Inc. • 42


--------------------------------------------------------------------------------

PART II



Business Transformation operating expenditures by reportable segment were as
follows:



In millions
                       Year Ended December 31,
                     2019          2018       2017
North America RWCS $    2.6       $ 10.8     $  5.5
International RWCS      1.3          0.7        4.0
All Other              63.8         71.1       21.8
Total              $   67.7       $ 82.6     $ 31.3


As part of our Business Transformation, we are undertaking legal entity
organizational restructuring actions to assist with streamlining and simplifying
business operations and to help lower general and administrative costs. Such
actions could result in additional charges associated with consulting and
professional fees and increases in potential exposure to U.S. and foreign taxes
and foreign exchange charges.

Intangible Amortization

For the years ended December 31, 2019, 2018, and 2017, we recognized $145.2
million, $130.3 million, and $118.4 million, respectively, of intangible
amortization expense. The increase is partially due to the adjustment of the
estimated useful lives of certain of our customer relationship intangibles (see
Part II, Item 8. Financial Statements and Supplementary Data; Note 7 - Goodwill
and Other Intangible Assets in the Consolidated Financial Statements) at the end
of 2018 with the remaining changes, net arising from acquisitions and
divestitures.

Acquisition and Integration

Details of the acquisitions completed in the years ended December 31, 2019, 2018, and 2017 can be found in Part II, Item 8. Financial Statements and Supplementary Data; Note 3 - Acquisitions in the Consolidated Financial Statements.

Acquisition and integration expenses were as follows:





In millions
                                                      Year Ended December 31,
                                            2019                 2018              2017
Acquisition expenses                   $          3.5       $          7.4     $        10.6
Integration expenses                                -                  2.2              30.5
Unfavorable (favorable) change in
contingent consideration                            -                  0.2              (0.4 )
Total                                  $          3.5       $          9.8     $        40.7


Acquisition expenses in all years principally comprise internal costs and
changes in deferred consideration. Integration expenses incurred in the years
ended December 31, 2018 and 2017 were primarily related to acquisitions
completed in the U.S. and, in particular, the Shred-it®
acquisition. Prospectively, baring new acquisitions, we anticipate acquisition
and integration expenses to be limited to deferred consideration changes, if
any.

Operational Optimization

We aim to achieve a culture of continuous improvement that will enhance its
efficiency, effectiveness and competitiveness to improve its cost base and cash
flow and we have taken a number of actions to reduce operating costs and
optimize operations. For example, we believe plant throughput and route density
are competitive strengths of Stericycle. We maintain such strengths by making
adjustments to our network of


2019 10-K Annual Report Stericycle, Inc. • 43


--------------------------------------------------------------------------------

PART II



transportation and treatment facilities to optimize overall logistics and
processing capabilities within a service category while reducing operational
costs. As part of these efforts, we seek to reduce network redundancies by
consolidating facilities, closing the redundant facility, and restructuring the
local organization and operation for efficiency.

Operational Optimization expenses, of which $9.8 million was recognized in COR
and $4.7 million was recognized in SG&A, for the year ended December 31, 2019,
were as follows:



In millions
                                    North America RWCS       International RWCS        All Other          Total
Exit costs - employee termination  $                0.4     $                0.9     $         1.0     $       2.3
Closure and exit costs - other                        -                      2.4                 -             2.4
Impairment and accelerated
depreciation of property, plant
and equipment                                       2.0                      4.0                 -             6.0
Impairment of intangibles                             -                      0.9               0.4             1.3
Total non-cash charges                              2.0                      4.9               0.4             7.3
Other expenses                                        -                      2.5                 -             2.5
Total                              $                2.4     $               10.7     $         1.4     $      14.5

Of the more significant charges:

• North America RWCS: Exit costs - employee termination related to employee

severance payments and non-cash charges related to impairment of long-lived

assets arising from a site relocation in the U.S.;

• International RWCS: Exit costs - employee termination and non-cash charges

relate to site closures and facility exits in EMEA and Latin America. Other

expenses primarily related to additional charges incurred as a result of

diverting waste processing during conversion at one of our plants in APAC; and

• All Other: Exit costs - employee termination relate to severance payments in

our Domestic CRS business to better align cost structure with associated

revenues and non-cash charges relate to an impairment of customer list

intangibles.

Operational Optimization expenses, which were all recognized in SG&A, for the year ended December 31, 2018, were as follows:





In millions
                                    North America RWCS       International RWCS        All Other          Total
Exit costs - employee termination  $                  -     $                0.2     $         1.1     $       1.3
Closure and exit costs - other                      4.2                      5.9               3.7            13.8
Impairment and accelerated
depreciation of property, plant
and equipment                                       1.0                      4.7                 -             5.7
Impairment of intangibles                             -                      6.6                 -             6.6
Total non-cash charges                              1.0                     11.3                 -            12.3
Other expenses                                        -                      2.0                 -             2.0
Total                              $                5.2     $               19.4     $         4.8     $      29.4

Of the more significant charges:

• North America RWCS: Closure and exit costs - other related to optimizing

overall logistics and sales functions, primarily related to our secure

information destruction locations and lease exit costs for the consolidation

of call centers in our Canadian CRS locations. Non-cash charges related to


      accelerated depreciation associated with software;



2019 10-K Annual Report Stericycle, Inc. • 44


--------------------------------------------------------------------------------

PART II

• International RWCS: Closure and exit costs - other related to closure,

contract exit and other clean-up costs, primarily in Latin America and

APAC. Non-cash impairment charges related to long-lived assets, customer

relationships, and operating permits, primarily in Latin America and APAC,

and rationalization of a tradename in Europe, and other expenses primarily

in APAC; and

• All Other: Closure and exit costs - other related to lease exit costs for

the consolidation of call centers in Domestic CRS locations.




Operational Optimization charges, which, except for $0.4 million which was
recognized in COR, were recognized in SG&A, for the year ended December 31,
2017, were as follows:



In millions
                                   North America
                                        RWCS           International RWCS       All Other          Total
Exit costs - employee termination  $          1.1     $                3.7     $        0.5     $       5.3
Closure and exit costs - other               16.1                      8.8              5.8            30.7
Impairment and accelerated
depreciation of property, plant
and equipment                                   -                      5.1                -             5.1
Impairment of intangibles                     3.1                     11.9              5.8            20.8
Total non-cash charges                        3.1                     17.0              5.8            25.9
Consulting and professional fees              8.9                        -              0.3             9.2
Total                              $         29.2     $               29.5     $       12.4     $      71.1

Of the more significant charges:

• North America RWCS: Closure and exit costs - other related to optimizing

overall logistics and sales functions, primarily related to our secure

information destruction locations. Non-cash impairment charges related to long

lived assets. Consulting and professional fees related to costs to identify

opportunities and reduce operational redundancies;

• International RWCS: Closure and exit costs - employee termination and closure

and exit costs - other included amounts incurred in Latin America for

rationalizing our operations and in the U.K. for facility rationalization and

contract exit costs. Non-cash impairment charges related to long-lived assets,

operating permits, and customer relationships in Latin America and APAC; and

• All Other: Closure and exit costs - other related to consolidating of call

centers in Domestic CRS locations. Non-cash charges relate to the impairment

of a tradename. Consulting and professional fees represented expenses incurred

to eliminate operational redundancies.




As we continue to consider each Operational Optimization activity, the amount,
the timing and recognition of charges will be affected by the occurrence of
commitments and triggering events as defined under U.S. GAAP, among other
factors. We may incur more charges and cash expenditures than estimated and may
not realize the expected improvement or cost savings on its planned time frame
or at all.

Divestitures

We evaluate our portfolio of services on an ongoing basis with a
country-by-country and service line-by-service line approach to assess long-term
potential and identify potential business candidates for divestiture. Any
decision to divest of a business is based upon several criteria, including the
following:

  • outlook for long-term market conditions;


  • potential impact to complementary services or customer relationships;


  • ability to leverage infrastructure and customer base for growth;



2019 10-K Annual Report Stericycle, Inc. • 45


--------------------------------------------------------------------------------

PART II

• potential for margin improvement, inclusive of vertical integration of


    collection and treatment;


  • current divestiture value versus future divestiture value;


  • return on invested capital;


  • impact on overall leverage, including impact on debt leverage ratio;


  • implications for ongoing internal control compliance efforts; and


  • implications for our ERP system implementation.


We recognized the following divestiture losses, net of (gains) associated with
divestitures of the following businesses (see Part II, Item 8. Financial
Statements and Supplementary Data; Note 4 - Restructuring and Divestitures in
the Consolidated Financial Statements.



In millions
                                          Year Ended December 31,
                                        2019          2018       2017
North America RWCS Segment
CRS businesses                        $     6.5      $    -     $    -
U.S. clean room business                      -         6.9          -
Total North America RWCS charges            6.5         6.9          -
International RWCS Segment
Mexico operations                          43.2           -          -
Chile operations                           19.0           -          -
U.K. TextAnywhere business                 (5.1 )         -          -
U.K. hazardous waste business               0.7         5.9        6.8
U.K. patient transport business            (0.3 )         -        5.7
South Africa operations                       -           -       (3.0 )
Total International RWCS charges, net      57.5         5.9        9.5
All Other
CRS businesses                             39.0           -          -
Total                                 $   103.0      $ 12.8     $  9.5


Included in the losses on divestiture of the Mexico and Chile operations were
charges of $18.9 million and $16.8 million, respectively, relating to the
recognition of losses accumulated on the associated cumulative currency
translation adjustments which were reclassified to earnings as of the date of
disposal.

In addition to these charges, in 2019 and 2018 we incurred $11.7 million and
$7.7 million, respectively, of consulting and professional fees associated with
our Portfolio Rationalization efforts. We did not incur any such fees in the
year ended December 31, 2017.

As part of our long-term strategy for improving profitability and return on
invested capital, we continue to evaluate the performance of our entire
portfolio of assets and businesses. Divestitures resulting from this ongoing
evaluation may cause us to record significant charges, including those related
to goodwill, other intangible assets, long-lived assets, and cumulative currency
translation adjustments. In addition, divestitures we complete may not yield the
targeted improvements in our business. Any charges that we are required to
record or the failure to achieve the intended financial results associated with
any divestiture we may complete as a result of our ongoing reviews could have a
material adverse effect on our business, financial condition or results of
operations.

We will continue monitoring businesses for achievement of the criteria that may
require classification as assets held-for-sale or for impairment as otherwise
required by applicable accounting standards. Our impairment evaluation is based
on the assumption that these assets or businesses will continue to be operated
by us as held-for-use until they are divested or classified as held-for-sale.



2019 10-K Annual Report Stericycle, Inc. • 46


--------------------------------------------------------------------------------

PART II

Litigation, Settlements and Regulatory Compliance



We operate in highly regulated industries and must address regulatory inquiries
or respond to investigations from time to time. We are also involved in a
variety of civil litigation from time to time including the items detailed in
Part II, Item 8. Financial Statements and Supplementary Data; Note 20 - Legal
Proceedings, in the Consolidated Financial Statements.

Our financial results may also include considerations of non-recurring matters
including settlements, environmental remediation, and legal related consulting
and professional fees.

For the year ended December 31, 2019, we recognized $28.2 million in regulatory compliance, consulting and professional fees, primarily related to certain litigation matters.



For the year ended December 31, 2018, we recognized $93.2 million of legal,
settlement and regulatory compliance expenses, consulting and professional fees,
primarily related to certain litigation matters, including the provision, net of
insurance recoveries, for the Securities Class Action Settlement announced on
December 19, 2018 and approved in July 2019.

For the year ended December 31, 2017, we recognized $327.7 million of legal,
settlement and regulatory compliance expenses, consulting and professional fees,
primarily related to certain litigation matters, of which $295.0 million was for
the SQ Settlement.

See also Item 1A. Risk Factor "We are subject to a number of pending lawsuits."

Asset and Goodwill Impairments

Asset impairment charges comprise the following:





In millions
                                                    Year Ended December 31,
                                                  2019         2018        2017
Software                                        $     1.6     $  17.6     $    -
Other property plant and equipment                    3.6           -       

-


Impairments included in COR                     $     5.2     $  17.6     $ 

-



Other property plant and equipment              $     0.5     $     -     $ 

-


Customer lists, permits and tradenames               16.4         8.9          -
Impairments included in SG&A                    $    16.9     $   8.9     $    -

Asset impairments                               $    22.1     $  26.5     $    -

Goodwill impairments:
Canada reporting unit                           $   126.6     $     -     $    -
Domestic Environmental Solutions reporting unit      80.8           -          -
Domestic CRS reporting unit                             -       286.3          -
Latin America reporting unit                         20.9        72.4       65.0
Goodwill impairments                            $   228.3     $ 358.7     $ 65.0


For the year ended December 31, 2019, impairment charges primarily consisted of
$1.6 million related to software as a result of rationalization of system
applications primarily in All Other, $1.0 million related to permits in Mexico
due to site closures prior to the Mexico operations divestiture, $0.7 million
related to customer list intangibles in the Netherlands, and $18.3 million
associated with property and equipment and customer relationship, permits and
other intangibles in our Brazil operations, both, which are part of our
International RWCS reportable segment and $0.5 million associated with a site
closure in our North


2019 10-K Annual Report Stericycle, Inc. • 47


--------------------------------------------------------------------------------

PART II



America RWCS reportable segment. For the year ended December 31, 2018, the
impairment charges were primarily associated to software in connection with our
evolving future information systems strategy including rationalization of
applications used within each reportable segment.  The impairment charges
included in SG&A and COR for the year ended December 31, 2019 and 2018,
respectively are further described in Part II, Item 8. Financial Statements and
Supplementary Data; Note 5 - Property, Plant and Equipment and Note 7 - Goodwill
and Other Intangible Assets in the Consolidated Financial Statements.

As a result of our annual goodwill impairment assessments on October 1 and
interim assessments, as applicable, we recognized goodwill impairment charges
which are discussed below in the Impairment section of Part II, Item 7.
Management's Discussion and Analysis of Financial Condition and Results of
Operations - Goodwill Impairment. (For additional information, see Part II, Item
8. Financial Statements and Supplementary Data; Note 7 - Goodwill and Other
Intangible Assets in the Consolidated Financial Statements).

Impairment charges may be recognized in future periods to the extent changes in
factors or circumstances occur, including deterioration in the macroeconomic
environment or in the equity markets, including the market value of our common
shares, deterioration in our performance or our future projections, or changes
in our plans for one or more reporting units or specified long-lived assets,
among other factors.

Other

During the years ended December 31, 2019, 2018, and 2017, we recognized $39.7
million, $29.1 million, and $24.8 million, respectively, of consulting and
professional fees related to internal control remediation activities as well as
the implementation of new accounting standards.

For the years ended December 31, 2019 and 2018, we recognized foreign exchange losses of $3.3 million and $3.8 million, respectively, related to the re-measurement of net monetary assets held in Argentina as a result of its designation as a highly inflationary economy.

Capital Allocation

Stericycle aims to maintain a structured capital allocation strategy that balances investment in the business, debt reduction, and returns to shareholders.

Our capital allocation items include the following types of activities:



  • Stock issuance costs,


  • Dividends on Preferred Stock,

• Debt modification costs in connection with related non-recurring matters,




  • Losses on early extinguishment of debt, and


  • Other related expenses.


For the year ended December 31, 2019, we incurred a pre-tax loss on early
extinguishment of debt of $23.1 million, comprising a "make-whole" premium of
$20.4 million, due under the terms of certain of the private placement notes,
and $2.7 million related to unamortized debt issuance costs, associated with
repayments of our private placement notes.

We also incurred $0.2 million of debt modification charges associated with the
execution of the Fourth Amendment, which are recorded in Interest expense, net
and charges of $3.4 million related to the write-



2019 10-K Annual Report Stericycle, Inc. • 48


--------------------------------------------------------------------------------

PART II



off of the unamortized portion of premiums associated with interest rate locks
executed in connection with the issuance of certain of the private placement
notes, which are recorded in Interest expense, net.

During the year ended December 31, 2018, we recognized $2.7 million of debt
modification charges related to amending our credit agreements. These charges
have been recognized as Interest expense, net in the Consolidated Statements of
(Loss) Income.

We declared and paid dividends of $25.5 million and $36.3 million, to the Series
A Preferred Stock shareholders during the years ended December 31, 2018 and
2017, respectively. On September 14, 2018, in accordance with their terms of
issuance, all of the Series A Preferred Stock was converted into common stock
and all then outstanding shares of preferred stock and the associated depositary
shares were cancelled.

Tax Reform

We analyzed the provisional impact of the Tax Act on our year end 2017 income
tax benefit/provision and as a result recognized $129.8 million as an income tax
benefit in 2017. Consistent with the requirements of Staff Accounting Bulletin
No. 118 ("SAB 118"), the analysis and determination of provisional impact was
finalized during 2018, resulting in a charge of $8.8 million. For further
discussion, see Part II, Item 8. Financial Statements and Supplementary Data;
Note 10 - Income Taxes in the Consolidated Financial Statements.

Results of Operations

Revenues (including Segment Revenue):



In analyzing our Company's performance, it is necessary to understand that our
various regulated services share a common infrastructure and customer base. We
market our regulated and compliance services by offering various pricing options
to meet our customers' preferences, and customers move between these different
billing paradigms. For example, our customers may contract with us for Medical
Waste Disposal services that are billed based on the weight of waste collected,
processed and disposed during a particular period, and in a subsequent period,
the same customer could move to our standard service, which packages the same
regulated medical waste services with training and education services for a
contracted subscription fee. Another example is a customer that purchases our
Medical Waste Disposal and Sharps Disposal Management services which provides
the customer with the same regulated services under a different pricing and
billing arrangement.

We do not track the movement of customers between the various types of regulated
services we offer. Although we can identify directional trends in our services,
because the regulated services are similar in nature and there are inherent
inaccuracies in disaggregation, we analyze revenues by revenue service category
and operating segment. We analyze our revenue growth by identifying changes
related to organic growth, acquisitions, divestitures and changes due to
currency exchange fluctuations. Organic growth excludes the effect of foreign
exchange and acquisitions and divestitures with less than a full year of
revenues in the comparative period.

Revenues and Gross profit associated with SID Services are impacted by changes
in SOP pricing, which has declined in recent quarters. Continued declines in SOP
pricing could have a material impact on our Revenues, Gross profit and results
of operations.

Regulated Waste and Compliance Services consist of Medical Waste and Compliance Solutions and Hazardous Waste Solutions. Communication and Related Services Revenues consist of Communications Services and Expert Solutions.

2019 10-K Annual Report Stericycle, Inc. • 49


--------------------------------------------------------------------------------

                                                                         PART II

2019 compared to 2018

Year over year movements in Revenues by Service Category and were as follows:



                                             In millions                                             Percentage Change %
                                Year Ended December 31,
                                                                                                                                         Foreign
                                  2019             2018         Change     Change     Organic         Acquisitions    Divestitures       Exchange
Revenues by Service
Regulated Waste and
Compliance Services           $    1,892.8       $ 1,932.6     $   (39.8 )    (2.1 %)      0.7 %                0.1 %          (0.5 %)         (2.4 %)
Secure Information                                                                                (1)
Destruction Services                 901.9           911.0          (9.1 )    (1.0 %)     (1.0 %)               0.9 %             -            (0.9 %)
Communication and Related
Services                             219.2           313.1         (93.9 )   (30.0 %)    (16.6 %)                 -           (13.0 %)         (0.4 %)
Manufacturing and Industrial
Services                             295.0           329.2         (34.2 )   (10.4 %)     (2.2 %)                 -            (4.1 %)         (4.1 %)
Total Revenues                $    3,308.9       $ 3,485.9     $  (177.0 )    (5.1 %)     (1.6 %)               0.3 %          (1.8 %)         (2.0 %)

Revenues by Segment
North America RWCS            $    2,544.2       $ 2,574.1     $   (29.9 )    (1.2 %)     (1.2 %) (2)           0.4 %          (0.2 %)         (0.2 %)
International RWCS                   579.3           655.1         (75.8 )   (11.6 %)      3.1 %  (3)             -            (4.9 %)         (9.8 %)
All Other                            185.4           256.7         (71.3 )   (27.8 %)    (17.5 %)                 -           (10.3 %)            -
Total Revenues                $    3,308.9       $ 3,485.9     $  (177.0 )    (5.1 %)     (1.6 %)               0.3 %          (1.8 %)         (2.0 %)



(1) Excluding SOP price impact, SID organic percentage change is 3.6% for the

year ended December 31, 2019.

(2) Excluding SOP price impact, North America RWCS organic percentage change

is 0.2% for the year ended December 31, 2019.

(3) Excluding SOP price impact, International RWCS organic percentage change

is 4.1% for the year ended December 31, 2019.




On a consolidated basis revenues decreased $177.0 million, or 5.1%, in 2019 to
$3.31 billion from $3.49 billion in 2018. The decrease was largely driven by the
impact of divestiture activity, foreign exchange, SOP pricing and reductions in
CRS, partially offset by organic growth in RWCS and SID due, among other things,
to the implementation of a recycling revenue surcharge.

North America RWCS revenues decreased $29.9 million, or 1.2%, in 2019 to $2.54
billion from $2.57 billion in 2018. Organic revenue declined $30.0 million, or
1.2%, as a result of approximately $35.0 million related to the impact of SOP
pricing partially offset by growth in SID. Acquisitions contributed $9.5
million, or 0.4%, to revenues and divestitures reduced revenues by $5.7 million
or 0.2%. The decline of the Canadian dollar had an unfavorable impact on 2019
revenues of $3.7 million, or 0.2%.

International RWCS revenue decreased $75.8 million, or 11.6%, in 2019 to $579.3
million from $655.1 million in 2018. Organic revenue increased in the
International RWCS segment in 2019 by $20.4 million, or 3.1%, primarily due to
higher volumes in RWCS revenues as a result of the implementation of new sales
strategies and higher SID revenues, due to higher volumes, and increases in
recycling surcharge revenue, offset by the impact of decreases in SOP
pricing. Divestitures of businesses, primarily the U.K hazardous waste business
in 2018, reduced revenues by $32.1 million, or 4.9%. The effect of foreign
exchange rates unfavorably impacted international revenues in 2019 by $64.1
million, or 9.8%, as foreign currencies declined against the U.S. dollar.



2019 10-K Annual Report Stericycle, Inc. • 50


--------------------------------------------------------------------------------

PART II



All Other revenues, related to Domestic CRS, decreased $71.3 million, or 27.8%,
in 2019 to $185.4 million from $256.7 million in 2018. Organic revenue decreased
$45.0 million, or 17.5%, primarily due to reductions in CRS volumes due to
smaller sized recall events and fewer mandated recalls as a result of the U.S.
Federal government shutdown in early 2019. Divestitures, primarily related to
the North America TAS and retail pharmaceutical returns businesses divested in
2019 reduced revenues by $26.3 million, or 10.3%.

2018 compared to 2017



                                          In millions                                           Percentage Change %
                              Year Ended December 31,
                                                                                                                                  Foreign
                                2018             2017        Change    Change     Organic     Acquisitions     Divestitures       Exchange
Revenues by Service
Regulated Waste and
Compliance Services         $    1,932.6       $ 2,023.6     $ (91.0 )    (4.5 %)     (2.8 %)           0.3 %           (1.1 %)         (0.9 %)
Secure Information
Destruction Services               911.0           823.4        87.6      10.6 %       7.8 %            2.7 %           (0.4 %)          0.5 %
Communication and Related
Services                           313.1           382.6       (69.5 )   (18.2 %)    (18.2 %)           0.1 %              -            (0.1 %)
Manufacturing and
Industrial Services                329.2           351.1       (21.9 )    (6.2 %)      2.8 %            0.2 %           (5.4 %)         (3.8 %)
Total Revenues              $    3,485.9       $ 3,580.7     $ (94.8 )    (2.7 %)     (1.5 %)           0.8 %           (1.3 %)         (0.7 %)

Revenues by Segment
North America RWCS          $    2,574.1       $ 2,551.9     $  22.2       0.9 %      (0.1 %)           1.1 %           (0.1 %)            -
International RWCS                 655.1           707.6       (52.5 )    (7.4 %)      1.9 %            0.4 %           (5.9 %)         (3.8 %)
All Other                          256.7           321.2       (64.5 )   (20.1 %)    (20.1 %)             -                -               -
Total Revenues              $    3,485.9       $ 3,580.7     $ (94.8 )    (2.7 %)     (1.5 %)           0.8 %           (1.3 %)         (0.7 %)


On a consolidated basis revenues decreased $94.8 million, or 2.7%, in 2018 to
$3.49 billion from $3.58 billion in 2017. The decrease was largely driven by the
expected declines in the SQ medical waste business and CRS, foreign exchange,
and divestitures, partially offset by strong organic growth in SID.

North America RWCS revenues increased $22.2 million, or 0.9%, in 2018 to $2.57
billion from $2.55 billion in 2017. Organic revenues decreased $1.5 million, as
we saw declines due to the impact of SQ pricing. This was partially offset by
increases in SID revenues as a result of increased pricing and related demand
for and SOP pricing increases related to recycled paper as well as organic
growth from new customers and growth in Regulated Waste and Compliance revenues
from retail and our larger customers. Acquisitions contributed $27.0 million, or
1.1%, to revenues. Divestitures, primarily related to the U.S. clean room
business, reduced revenues by $3.3 million, or 0.1%.

International RWCS revenue decreased $52.5 million, or 7.4%, in 2018 to $655.1
million from $707.6 million in 2017. The increase in International RWCS segment
organic revenues was $13.3 million, or 1.9%. SID revenues increased as a result
of increased pricing and related demand and SOP pricing for recycled paper as
well as organic growth from new customers, and the impact of the new General
Data Protection Regulation laws in Europe. We also saw increases in Medical
Waste and Compliance Revenues as a result of growth in Europe. These increases
were offset by declines due to the exit from our patient transport business in
the U.K. and overall economic declines in several Latin America
markets. Acquisitions in the International RWCS segment contributed $2.7
million, or 0.4%, to revenues. Divestitures related to the hazardous waste
business in the U.K. and SID business in South Africa reduced revenues by $41.7
million, or 5.9%. The effect of foreign exchange rates, primarily in Latin
America, unfavorably impacted



2019 10-K Annual Report Stericycle, Inc. • 51


--------------------------------------------------------------------------------

PART II

international revenues in 2018 by $26.8 million, or 3.8%, as foreign currencies, notably those in Latin America, declined against the U.S. dollar.



All Other revenues, related to Domestic CRS, decreased $64.5 million, or 20.1%,
in 2018 to $256.7 million from $321.2 million in 2017. Revenues were impacted by
reductions in CRS volumes due to smaller-sized recall events as compared to
multiple large-sized recall events managed during 2017 and lower call volumes.

Gross Profit



In millions
                                             Year Ended December 31,
                        2019                           2018                           2017                   Change 2019 versus 2018           Change 2018 versus 2017
                 $        % of Revenue          $        % of Revenue      

   $        % of Revenue            $               %                  $               %
Gross profit   1,174.5             35.5 %     1,376.0             39.5 %     1,462.5             40.8 %          (201.5 )         (14.6 %)           (86.5 )         (5.9 %)


Consolidated Gross profit decreased $201.5 million, or 14.6%, in 2019 to $1.17
billion from $1.38 billion in 2018. As a percentage of revenues, consolidated
Gross profit decreased to 35.5% in 2019 compared to 39.5% in 2018. The decline
in gross profit was primarily due to the impact of higher operational costs,
including third-party disposal in hazardous waste operations, equipment
maintenance and rental costs as well as the impact of SOP pricing declines.

Consolidated Gross profit decreased $86.5 million, or 5.9%, in 2018 to $1.38
billion from $1.46 billion in 2017. As a percentage of revenues, consolidated
Gross profit decreased to 39.5% in 2018 compared to 40.8% in 2017. The decline
in gross profit was primarily attributable to the expected impact of SQ mix and
pricing, approximately $25.7 million of impairment charges incurred in the North
America RWCS and All Other reportable segments and the impact of lower volumes
in CRS. Decreases were also due to a prolonged declining market trend and cost
pressures in Latin America.

International gross profit is lower than domestic gross profit because our
international operations have fewer small account customers, which tend to
generate higher gross profit. Historically, our international operations
generate most of their revenues from large account customers, such as hospitals,
publicly funded healthcare organizations and government bodies. As our
international revenues increase, consolidated gross profit percentages
experience downward pressure due to this "business mix" shift, which may be
offset by additional international small account market penetration, integration
savings, and domestic business expansions.

SG&A



In millions
                                               Year Ended December 31,
                          2019                           2018                           2017                   Change 2019 versus 2018            Change 2018 versus 2017
                   $        % of Revenue          $        % of Revenue    

     $        % of Revenue            $                %                 $               %
SG&A             1,055.1             31.9 %     1,165.6             33.4 %     1,395.6             39.0 %           (110.5 )         (9.5 %)          

(230.0 ) (16.5 %)




SG&A expenses decreased $110.5 million, or 9.5%, in 2019 to $1.06 billion from
$1.17 billion in 2018. As a percentage of revenues, SG&A decreased to 31.9% of
revenues in 2019 compared to 33.4% in 2018. The decrease was primarily the
result of lower charges associated with key priorities and other significant
matters, discussed above, which were $317.4 million in 2019 compared to $382.9
million in 2018 and


2019 10-K Annual Report Stericycle, Inc. • 52


--------------------------------------------------------------------------------

PART II

lower incentive compensation.



SG&A expenses decreased $230.0 million, or 16.5%, in 2018 to $1.17 billion from
$1.40 billion in 2017. As a percentage of revenues, SG&A decreased to 33.4% in
2018 compared to 39.0% in 2017. The decrease was primarily attributable to lower
charges associated with key priorities and significant matters, which were
$382.9 million in 2018 compared to $612.9 million in 2017. These matters are
discussed above. Additionally, there were also decreases in consulting and
professional fees and bad debt expense partially offset by an increase in
incentive compensation as achievement was at higher overall levels during 2018.

Goodwill Impairment



In millions
                                                Year Ended December 31,
                             2019                         2018                        2017                  Change 2019 versus 2018           Change 2018 versus 2017
                       $      % of Revenue         $       % of Revenue         $      % of Revenue
Goodwill impairment   228.3             6.9 %     358.7             10.3 %      65.0             1.8 %          (130.4 )         (36.4 %)          293.7           451.8 %

Goodwill impairment was $228.3 million in 2019, $358.7 million in 2018, and $65.0 million in 2017.

We performed our annual goodwill assessment as of October 1, 2019, and as a result we determined that our Canada and Domestic Environmental Solutions reporting units' carrying values were in excess of their estimated fair values.



The following factors contributed to changes in our long-range plan approved in
the fourth quarter, which negatively impacted the estimated fair value of these
reporting units:

• Domestic Environmental Solutions: During 2019, we experienced higher

operating costs, particularly related to hazardous waste disposal costs. In

addition, we anticipate that the timelines for achieving the betterment

plans for both revenue quality and cost improvements have been extended. We


       also gathered insights from the process of evaluating Domestic
       Environmental Solutions as part of our portfolio rationalization
       considerations.

Canada: During 2019, we experienced competitive pricing pressure in SID and

Regulated Medical Waste Services, lower SOP pricing, and higher medical and

hazardous waste costs including Canada based operating costs due to a

reliance on third-party disposal, and U.S. based enabling support costs. We


       expect these challenges to have a prolonged impact and have adjusted for
       them in our current year long-range plan.


These challenges were factored into updates to our long-range plan and
forecasted cash-flow assumptions to reflect our current outlook. We also made
certain adjustments to the discount rates used to present value these forecasted
cash-flows. As a result, we recognized $126.6 million to fully impair the
goodwill associated with our Canada reporting unit and $80.8 million of non-cash
impairment charges related our Domestic Environmental Solutions reporting unit.

During the first quarter of 2019, there were business, market, and strategic
developments which negatively impacted the estimated cash flows of our Latin
America reporting unit and triggered an interim assessment as of March 31,
2019. We determined that the Latin America reporting unit's carrying value was
in excess of its estimated fair value and recognized $20.9 million of non-cash
goodwill impairment

During 2018, as a result of our annual impairment assessment of goodwill, we
recognized a non-cash goodwill impairment charge for our Domestic CRS and Latin
America reporting units of $286.3 million and $72.4 million, respectively.



2019 10-K Annual Report Stericycle, Inc. • 53


--------------------------------------------------------------------------------

PART II

During 2017, as a result of our annual impairment assessment of goodwill we recognized a non-cash goodwill impairment charge for our Latin America reporting unit of $65.0 million.



Segment Profitability

We use Adjusted EBITDA as the primary measure of profitability for each of our
Reportable Segments - see Part II, Item 8. Financial Statements and
Supplementary Data; Note 18 - Segment Reporting in the Consolidated Financial
Statements for an explanation of this measure. Segment profitability and a
reconciliation of the total for segment profitability to (loss) income from
operations was as follows:



In millions
                                                  Year Ended December 31,
                              2019                         2018                         2017                   Change 2019 versus 2018           Change 2018 versus 2017
                                % of Segment                 % of Segment                 % of Segment
                        $         Revenues           $         Revenues           $         Revenues              $               %                  $               %
Adjusted EBITDA
North America RWCS      643.2           25.3 %       782.4           30.4 %       809.5           31.7 %           (139.2 )         (17.8 %)           (27.1 )         (3.3 %)
International RWCS       99.0           17.1 %        95.6           14.6 %        93.7           13.2 %              3.4             3.6 %              1.9            2.0 %
All Other              (164.4 )        (88.7 %)     (133.4 )        (52.0 %)      (91.2 )        (28.4 %)           (31.0 )          23.2 %            (42.2 )         46.3 %
Total                   577.8           17.5 %       744.6           21.4 %       812.0           22.7 %           (166.8 )         (22.4 %)           (67.4 )         (8.3 %)


Reconciliation to
Loss from
operations:
Total Adjusted
EBITDA above            577.8                        744.6                        812.0
Depreciation           (125.8 )                     (125.6 )                     (131.1 )
Intangible
Amortization           (145.2 )                     (130.3 )                     (118.4 )
Business
Transformation          (67.7 )                      (82.6 )                      (31.3 )
Acquisition and
Integration              (3.5 )                       (9.8 )                      (40.7 )
Operational
Optimization            (14.5 )                      (29.4 )                      (71.1 )
Divestitures
(including
Divestiture Losses,
net of Gains)          (114.7 )                      (20.5 )                       (9.5 )
Litigation,
Settlements and
Regulatory
Compliance              (28.2 )                      (93.2 )                     (327.7 )
Asset Impairments       (22.1 )                      (26.5 )                          -
Goodwill Impairment    (228.3 )                     (358.7 )                      (65.0 )
Other                   (39.7 )                      (29.1 )                      (24.8 )
Loss from operations   (211.9 )                     (161.1 )                       (7.6 )


2019 compared to 2018

Adjusted EBITDA for our North America RWCS reportable segment decreased $139.2
million, or 17.8%, in 2019 to $643.2 million from $782.4 million in 2018. As a
percentage of North America RWCS revenues, Adjusted EBITDA was 25.3% and 30.4%
for 2019 and 2018, respectively. This decrease was primarily a result of
lower gross margins due to the impact of higher operational costs, including
third-party disposal in hazardous waste operations, equipment maintenance and
rental costs as well as the impact of SOP pricing declines.



2019 10-K Annual Report Stericycle, Inc. • 54


--------------------------------------------------------------------------------

PART II



Adjusted EBITDA for our International RWCS reportable segment increased $3.4
million, or 3.6%, in 2019 to $99.0 million from $95.6 million in 2018. As a
percentage of International RWCS revenues, Adjusted EBITDA was 17.1% and 14.6%
for 2019 and 2018, respectively. The increase as a percentage of revenues was
primarily the result of a higher gross profit percentage in Europe as a result
of the divestitures of lower margin businesses in 2018 and lower SG&A expenses,
offset by lower operating margins in Latin America due to the impact of lower
volumes and decreases in SOP pricing in Europe.

Adjusted EBITDA for All Other decreased $31.0 million, or 23.2%, in 2019 to
$(164.4) million from $(133.4) million in 2018. The decrease is a result of
lower revenues in our Domestic CRS business due to smaller sized recall events
and fewer mandated recalls as a result of the U.S. Federal government shutdown
in early 2019, combined with disproportionally lower gross profits due to the
higher fixed cost nature of this business and higher corporate enabling
functional expenses.

2018 compared to 2017



Adjusted EBITDA for our North America RWCS reportable segment decreased $27.1
million, or 3.3%, in 2018 to $782.4 million from $809.5 million in 2017. As a
percentage of North America RWCS revenues, Adjusted EBITDA was 30.4% and 31.7%,
for 2018 and 2017, respectively. This decrease was primarily a result of the
impact of lower margins caused by the expected impact of pricing on our SQ
medical waste customers as well as the pricing pressures we have experienced
from our SQ regulated waste and compliance customers resulting from hospital
consolidation of physician practices and increased competitive activities,
partially offset by the impact of Business Transformation cost savings and
efficiencies. Additionally, the overall decrease was partially offset by the
benefits of increased volume and higher SOP pricing.

Adjusted EBITDA for our International RWCS reportable segment increased $1.9
million, or 2.0%, in 2018 to $95.6 million from $93.7 million in 2017. As a
percentage of International RWCS revenues, Adjusted EBITDA was 14.6% and 13.2%
for 2018 and 2017, respectively. We experienced improvements in overall margins
in Europe as a result of our exit from some lower margin businesses. These
improvements were partially offset by lower margins in Latin America due to a
prolonged declining market trend and costs pressures.

Adjusted EBITDA for All Other decreased $42.2 million in 2018 to $(133.4) million from $(91.2) million in 2017. The decrease is a result of the lower revenues in our Domestic CRS business combined with disproportionally lower gross profits due to the higher fixed costs nature for this business.



Interest Expense, Net



In millions
                                       Year Ended December 31,
                     2019                      2018                       2017                   Change 2019 versus 2018             Change 2018 versus 2017
                $       % Revenue         $       % Revenue         $      % of Revenue            $                 %                 $                 %
Interest
expense, net   118.3           3.6 %     106.0           3.0 %      93.7             2.6 %            12.3              11.6 %            12.3          

13.1 %




Interest expense, net increased in 2019 to $118.3 million from $106.0 million in
2018 due to an overall increase in interest rates charged on our borrowings
caused by an increase in the LIBOR rate and interest rate adjustments. The
interest rate adjustments were calculated under the terms of the relevant
agreements, related to both our private placement notes, prior to their early
extinguishment, and the Senior Credit Facility combined with an overall increase
in our average outstanding debt balance. Further,



2019 10-K Annual Report Stericycle, Inc. • 55


--------------------------------------------------------------------------------

PART II

for 2019, Interest expense, net includes a non-cash charge of $3.4 million, together with a further $0.2 million which are detailed in Capital Allocation, above.



Interest expense, net increased in 2018 to $106.0 million from $93.7 million in
2017 due to an increase in the overall interest rates on our borrowings caused
by an increase in the LIBOR rate and interest rate adjustments. The higher
interest rates were a result of higher rates as calculated under the terms of
the relevant agreements, related to both our private placement notes and Senior
Credit Facility combined with an overall increase in our average outstanding
debt balance primarily due to funding the SQ settlement payment of $295.0
million using amounts available on our Senior Credit Facility.

We capitalized interest of $5.4 million, $2.9 million and $1.6 million for the
years ended December 31, 2019, 2018 and 2017, respectively. Interest
capitalization is based upon the balance of construction in progress within
property plant and equipment and is primarily comprised of amounts associated
with our ERP implementation. As the ERP becomes operational amounts will be
reclassified from construction in progress, thereby reducing the amount of
interest which is capitalized, increasing the amount recognized as interest
expense.

In addition, based on the terms of the amendment to the Credit Agreement signed
on February 25, 2020 we expect that our annual interest expense will increase by
approximately $2.0 million.

Loss on Early Extinguishment of Debt



During 2019, we incurred a pre-tax loss on early extinguishment of debt of $23.1
million, relating to the repayment of our private placement notes, discussed in
Capital Allocation above.

Other Expense, Net

Other expense, net increased in 2019 to $9.5 million from $8.3 million in 2018.
Other expense includes $3.3 million and $3.8 million in 2019 and 2018,
respectively, relating to the foreign exchange loss resulting from the
re-measurement of our Argentina Peso denominated net monetary assets as a result
of the designation, as of July 1, 2018, of Argentina as a highly inflationary
economy.,

Other expense, net increased in 2018 to $8.3 million from $6.6 million in 2017, primarily due to a $3.8 million foreign exchange loss resulting from the re-measurement of our Argentinian Peso denominated net monetary assets.



Income Tax Benefit



In millions
                                                   Year Ended December 31,
                              2019                           2018                           2017                  Change 2019 versus 2018            Change 2018 versus 2017
                      $       Effective rate         $       Effective rate         $       Effective rate           $               %                  $               %
Income tax benefit    16.8                4.6 %      29.8               10.8 %     150.9              139.9 %          (13.0 )         (43.6 %)          (121.1 )         (80.3 %)


Income tax benefit was $16.8 million in 2019 compared to income tax benefit of
$29.8 million in 2018. The effective tax rates for the years 2019 and 2018 were
4.6% and 10.8%, respectively. In 2019 and 2018, our effective rate was impacted
by the non-deductibility of a portion of the goodwill impairments in certain
jurisdictions, and valuation allowances recognized against net operating losses
in several countries.

Income tax benefit was $29.8 million in 2018 compared to $150.9 million in
2017. The effective tax rates for the years 2018 and 2017 were 10.8% and 139.9%,
respectively. During 2017, as a result of the introduction of the Tax Act, we
recognized an income tax benefit of $129.8 million arising from the



2019 10-K Annual Report Stericycle, Inc. • 56


--------------------------------------------------------------------------------

PART II



revaluation of our U.S. net deferred tax liabilities from 35% to the newly
enacted U.S. corporate income tax rate of 21%, partially offset by a one-time
transition tax on our unremitted foreign earnings and profits which we elected
to pay over an eight-year period, and expected foreign withholding taxes. During
2018, in accordance with SAB 118, we recognized a charge of $8.8 million as we
completed our analysis associated with the impact of the Tax Act. In addition,
in 2018 and 2017 our effective rate was also impacted by the non-deductibility
of the goodwill impairments in certain jurisdictions, and valuation allowances
recognized against net operating losses in several countries.

We file income tax returns in the United States, in various states and in
certain foreign jurisdictions. We are no longer subject to U.S. federal, state,
local, or non-US income tax examinations by tax authorities for years prior to
2015.

The Company filed a PFA with the IRS related to a claim under Internal Revenue
Code Section 1341 concerning the tax rate to be applied to the SQ Settlement on
the Company's 2018 tax return. The IRS has reviewed and has subsequently agreed
to hold discussions regarding the PFA in 2020.

During the year ended December 31, 2018, the Company had established a long-term
receivable and an amount within the uncertain tax positions to reflect its
estimate of the potential refund should its claim be successful. The long-term
receivable is included in Other Assets, while the uncertain tax position
liability is included in Other Liabilities in the Consolidated Balance Sheets as
of December 31, 2019 and 2018. Any positive income tax benefit resulting from
the claim in a future period will be recognized as appropriate in accordance
with the guidance in ASC 740 on the accounting for uncertain tax positions. The
long-term receivable is in addition to the net operating loss assets, included
in Other assets in the Consolidated Balance Sheets. There can be no assurance
that this amount or any amount will be recovered as a result of this claim.

Liquidity and Capital Resources



Details of our outstanding debt obligations can be found in Part II, Item 8.
Financial Statements and Supplementary Data; Note 9 - Debt in the Consolidated
Financial Statements.

We believe that we have sufficient liquidity to support our ongoing operations,
including the ERP implementation, and to invest in future growth to create value
for our shareholders. Operating cash flows and the $1.2 billion Senior Credit
Facility are our primary sources of liquidity and are expected to be used for,
among other things, payment of interest and principal on our long-term debt
obligations and capital expenditures necessary to support growth and
productivity improvements, including those associated with our ERP
implementation. To the extent our liquidity needs prove to be greater than
expected or cash generated from operations is less than anticipated, and cash on
hand or credit availability is insufficient or we are in breach under the
existing Credit Agreement, we would need to seek additional financing from
alternative sources, including approaching the capital markets, in order to
provide additional liquidity.

On February 25, 2020, we executed the Fifth Amendment which amended the Credit Agreement to, among other things:

• increase the maximum allowable Consolidated Leverage Ratio to 5.00 to 1.00

until the end of the first quarter of 2022 and 4.50 to 1.00 thereafter.

• upon the consummation of the divesture of the ESOL Disposal Group, each of

the foregoing maximum permitted Consolidated Leverage Ratio levels will


        step down to 4.75 to 1.00 and 4.25 to 1.00, respectively.



2019 10-K Annual Report Stericycle, Inc. • 57


--------------------------------------------------------------------------------

                                                                         PART II

    •   allow for continuation of the $200 million of cash add backs to EBITDA

through December 31, 2020, and addbacks of $100 million until December 31,

2021, with no further addbacks thereafter.

• increase the leverage ratio pricing tier of greater than 4.50 to 1.00 by

0.125%,

• grant a first-priority security interest to the administrative agent for

the benefit of the lenders in substantially all of the personal property

of the Company and certain of its material domestic subsidiaries,

including certain equity interests held by those entities.

We expect to incur facility and other fees of approximately $2.0 million in connection with the execution of the Fifth Amendment.



The Credit Agreement and Fifth Amendment contain a number of covenants,
including financial covenants. As of December 31, 2019 we were in compliance
with the Consolidated Leverage Ratio covenant, with an actual ratio of 4.45 to
1.00, which was below the allowed maximum ratio of 5.00 to 1.00 as contained in
the Fifth Amendment.

Working Capital

At December 31, 2019, our working capital decreased $64.4 million to a deficit
of $50.3 million compared to $14.1 million at December 31, 2018. This change is
primarily related to the recognition of Operating lease liabilities associated
with the adoption of ASC 842, and the impact of divestitures and increased
collections, partially offset by an increase in Prepaid expenses, and decreases
in Accrued liabilities and Bank overdrafts.

Current assets decreased $40.7 million in 2019 to $706.6 million from $747.3
million in 2018. Increases in Prepaid expenses as a result of increases in
prepaid software-as-a-service fees were partially offset by declines in accounts
receivable as a result of divestitures and increased collections. Days sales
outstanding ("DSO") was 60 days and 63 days as of December 31, 2019 and 2018,
respectively.

Current liabilities increased $23.7 million in 2019 to $756.9 million from
$733.2 million in 2018, primarily as a result of the adoption of ASC 842, which
now requires recognition of Operating lease liabilities on the Consolidated
Balance Sheet. This increase was partially offset by decreases in Accrued
liabilities, due to timing of payments related to 2018 annual incentive plans,
and a decrease in Bank overdrafts, as we used a portion of the proceeds from the
divestiture of a business to reduce overdraft balances in the U.K.



In millions
                                                    Year Ended December 31,
                                           2019              2018              2017

Net cash from operating activities $ 248.0 $ 165.7 $ 508.6 Net cash from investing activities

            (104.0 )          (147.5 )          (193.0 )
Net cash from financing activities            (141.6 )           (25.7 )          (321.2 )
Effect of exchange rate changes on
cash and cash equivalents                       (2.0 )            (0.4 )             3.6
Net change in cash and cash
equivalents                            $         0.4     $        (7.9 )   $        (2.0 )


Operating Cash Flows: Net cash from operating activities increased $82.3
million, or 49.7%, in 2019 to $248.0 million from $165.7 million in 2018. Cash
flow from operations in 2018 is lower, primarily as a result of the payment of
the $295.0 million SQ settlement. Excluding the settlement payment, cash flow
from operations decreased $212.7 million, primarily due to lower operating
performance in 2019, as previously highlighted, and payments in 2019 for certain
litigation matters, 2018 incentive compensation and ERP-related prepaid
software.

Investing Cash Flows: Net cash used in investing activities decreased $43.5 million, or 29.5%, in 2019 to $104.0 million from $147.5 million in 2018. Our capital expenditures increased by $63.4 million to $194.2

2019 10-K Annual Report Stericycle, Inc. • 58


--------------------------------------------------------------------------------

PART II



million from $130.8 million in 2018, primarily as a result of capital
expenditure payments associated with our ERP implementation. We also received
$86.6 million from the divestiture of businesses during 2019 and the receipt of
a note receivable issued in connection with the divestiture of our U.K.
hazardous waste business in 2018. Payments for acquisitions, net of cash
acquired, decreased by $44.5 million as we completed only one acquisition in
2019 versus 21 in 2018.

Financing Cash Flows: Net cash used in financing activities increased $115.9
million, or 451.0%, in 2019, to a net outflow of $141.6 million from a net
outflow of $25.7 million in 2018. In June 2019, we raised proceeds of $600.0
million from our issuance of the Senior Notes and used the proceeds, net of
issuance costs, together with additional borrowings on our Senior Credit
Facility and Term Loan, to repay in full approximately $1.075 billion of the
then outstanding balance on private placement notes. As a result of this
repayment, we also incurred a "make-whole" premium of $20.4 million, payable
under the terms of certain of the private placement notes. Our net borrowings on
our Senior Credit Facility and Term Loan were $446.3 million, including the
additional Term Loan of $365.0 million, in 2019 compared to net borrowings of
$68.7 million in 2018, primarily as a result of additional borrowings to finance
the repayment of the private placement notes. We made repayments of $12.5
million in 2019, including using a portion of the proceeds from the divestiture
of a business to reduce our bank overdraft in the U.K. We made Series A
repurchases of $17.2 million and paid dividends of $25.5 million to the holders
of Series A during 2018. The Series A was converted, in accordance with its
terms of issuance, to common stock in September 2018 and as a result no
dividends were due or payable during 2019.

Contractual Obligations

The following table summarizes our significant contractual obligations and cash commitments at December 31, 2019:

Payments due by period (in millions)


                                 Total         2020        2021-2022       2023-2024       2025 and After
Long term debt (1)             $ 2,646.2     $    98.0     $  1,936.6     $     610.3     $            1.3
Finance lease liabilities           34.5           6.5           10.5             5.5                 12.0

Operating lease liabilities 508.2 112.6 172.9


    113.7                109.0
Estimated unconditional
purchase obligations               229.3         159.1           52.6            17.6                    -
Total contractual cash
obligations                    $ 3,418.2     $   376.2     $  2,172.6     $     747.1     $          122.3



(1) These amounts represent the scheduled principal payments related to our

long-term debt, excluding interest (see Part II, Item 8. Financial

Statements and Supplementary Data; Note 9 - Debt in the Consolidated

Financial Statements).

Payments for unrecognized tax benefits are excluded from contractual obligations. Based on the uncertain nature of our liability for unrecognized tax benefits, we are unable to make an estimate of the period of potential settlement, if any, with the applicable taxing authorities.

We had elected to pay our $23.5 million transition tax liability over eight years. We are in a net receivable position with the IRS due to estimated payments and credits for tax periods through 2019. The IRS has offset the transition tax payable with these payments and credits on deposit with the IRS.



Environmental liabilities are not presented above but are accrued on an
undiscounted basis and are associated with identified sites where an assessment
has indicated that cleanup costs are probable and can be reasonably estimated
but the timing of such payments is not fixed and determinable (see Part II, Item
8. Financial Statements and Supplementary Data; Note 12 - Commitments and
Contingencies in the Consolidated Financial Statements).



2019 10-K Annual Report Stericycle, Inc. • 59


--------------------------------------------------------------------------------

PART II



As of December 31, 2019, we had $33.0 million of stand-by letters of credit
outstanding against our senior credit facility and a further $52.3 million of
stand-by letters of credit outstanding against another facility, $72.3 million
of surety bonds, and $19.3 million of bank guarantees. The bank guarantees are
issued mostly by our international subsidiaries for various purposes, including
leases, seller notes, contracts and permits. The surety bonds are used for
performance guarantees. Neither the bank guarantees nor the surety bonds affect
our ability to use our various lines of credit.

We anticipate that our operating cash flows, together with additional borrowings
available under our Senior Credit Facility, as amended on February 25, 2020,
will be sufficient to meet our anticipated future operating expenses, key
priorities such as our ERP implementation, capital expenditures and debt service
obligations as they become due during the next 12 months and the foreseeable
future.

Critical Accounting Policies and Estimates



Our discussion and analysis of our financial condition and results of operations
are based upon our consolidated financial statements, which have been prepared
in accordance with U.S. GAAP. The preparation of these financial statements
requires management to make estimates, assumptions and judgments that affect the
reported amounts of assets, liabilities, revenues and expenses, and the related
disclosure of contingent assets and liabilities. Although management believes
that its estimates and assumptions are reasonable, they are based upon
information available when they are made, and therefore, actual results may
differ from these estimates under different assumptions or conditions. Our most
critical accounting policies are those that may be material due to the levels of
subjectivity and judgment necessary to account for highly uncertain matters or
the susceptibility of such matters to change, and those policies that have a
material impact on the financial condition or operating performance of the
Company. Part II, Item 8. Financial Statements and Supplementary Data; Note 1 -
Basis of Presentation and Summary of Significant Accounting Polices in the
Consolidated Financial Statements provides a detailed description of all of our
material accounting policies however, we have identified the following as our
most critical accounting policies and estimates.

Revenue Recognition

Revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these good or services. Revenue is recognized net of revenue-based taxes assessed by governmental authorities.



We provide regulated waste and compliance services, which include the collection
and processing of regulated and specialized waste for disposal, the collection
of personal and confidential information for secure destruction, and Expert
Solutions, and communication services. The associated activities for each of
these are a series of distinct services that are substantially the same and have
the same pattern of transfer over time; therefore, the respective services are
treated as a single performance obligation.

We recognize revenue by applying the right to invoice practical expedient as our
right to consideration corresponds directly to the value provided to the
customer for performance to date. Revenues for our Regulated Medical Waste
Solutions and Secure Information Destruction Services are recognized upon waste
collection. Our Compliance Solution revenues are recognized over the contractual
service period. Revenues from Hazardous Waste Solutions and Manufacturing and
Industrial Services are recognized at the time the waste is received by a
facility with an appropriate permit, either our processing facility or a third
party. Revenues from Communication Services and Expert Solutions are recorded as
the services are performed.


2019 10-K Annual Report Stericycle, Inc. • 60


--------------------------------------------------------------------------------

PART II

Allowance for Doubtful Accounts



We report accounts receivable at their net realizable value, which is
management's best estimate of the cash that will ultimately be received. We
maintain an allowance for doubtful accounts to reflect the expected
uncollectability of accounts receivable based on historical collection data and
specific risks identified among uncollected accounts. If current economic
trends, events, or changes in circumstances indicate that specific receivable
balances may be impaired, further consideration is given to the collectability
of those balances and the allowance is adjusted accordingly. The adequacy of
allowances for uncollectible accounts is reviewed at least quarterly, and
adjusted as necessary based on such reviews. Management's judgment is required
to assess the collectability of an account, based on detailed analysis of the
aging of the receivables, the creditworthiness of our customers, historical
collection trends and current economic trends.

Accounts receivable written off in subsequent periods can differ from the allowance for doubtful accounts provided, but historically our provision has been adequate. Allowance for doubtful accounts was $67.9 million and $71.9 million as of December 31, 2019 and 2018, respectively.

Impairment of Long-Lived and Other Assets



Property, Plant and Equipment and Intangible Assets (definite-lives), Net:
Long-lived assets, such as property, plant and equipment and amortizing
intangible assets are reviewed whenever events or changes in circumstances
indicate that the related carrying amounts may not be recoverable. Impairment of
assets with definite-lives is generally determined by comparing projected
undiscounted cash flows to be generated by the asset, or appropriate grouping of
assets, to its carrying value. If impairment is identified, a loss is recognized
equal to the excess of the asset's net book value over its fair value, and the
cost basis is adjusted.

Determining the extent of impairment, if any, typically requires various
estimates and assumptions including using management's judgment, cash flows
directly attributable to the asset, the useful life of the asset and residual
value, if any. When necessary, the Company uses internal cash flow estimates,
quoted market prices and appraisals as appropriate to determine fair
value. Actual results could vary from these estimates. In addition, the
remaining useful life of the impaired asset is revised, if necessary.

(For additional information, see Part II, Item 8. Financial Statements and Supplementary Data; Note 5 - Property, Plant and Equipment and Note 7 - Goodwill and Other Intangible Assets in the Consolidated Financial Statements).



Intangible Assets (indefinite-lived): Indefinite-lived intangibles consist
primarily of permits and tradenames. Indefinite-lived intangibles are assessed
for impairment annually, as of October 1, or more frequently if an event occurs
or circumstances change and are not subject to amortization but are assessed for
impairment in the same manner as goodwill. Indefinite lived intangibles may be
assessed using either a qualitative or quantitative approach.  The qualitative
approach first determines if it is more-likely-than-not that the fair value of
the asset is less than the carrying value.  If no such determination is made,
then the impairment test is complete.  If, however, it is determined that there
is a likely impairment, a quantitative assessment is performed.  In the fourth
quarter of 2019, we performed our annual impairment test on indefinite-lived
intangibles, other than goodwill, using the qualitative approach for certain
assets and the quantitative approach for the remaining assets. The calculated
fair value of our indefinite-lived intangibles is based upon, among other
things, certain assumptions about expected future operating performance,
internal and external processing costs, and an appropriate discount rate
determined by management.



2019 10-K Annual Report Stericycle, Inc. • 61


--------------------------------------------------------------------------------

PART II



Future changes in our assumptions or the interrelationship of the assumptions
described above may negatively impact future valuations that would require
non-cash charges and may have a material effect on our financial condition and
operating results.

Goodwill: Goodwill is assessed for impairment annually as of October 1 of each
year, or more frequently if an event occurs or circumstances change that could
reduce the value of a reporting until below its carrying value.

We used a quantitative approach to assess goodwill for impairment. The fair
value of each reporting unit is calculated using the income approach (including
DCF) and validated using a market approach with the involvement of a third-party
valuation specialist. Our reporting units are: Domestic Healthcare Compliance
Services, Domestic Shred-it, Domestic CRS, Domestic Environmental Solutions,
Canada, Europe, Asia Pacific and Latin America. The income approach uses
expected future cash flows of each reporting unit and discounts those cash flows
to present value.  Expected future cash flows are calculated using management
assumptions of growth rates, including long-term growth rates, capital
expenditures, and cost efficiencies.  Future acquisitions are not included in
the expected future cash flows. We use a discount rate based on a calculated
weighted average cost of capital which is adjusted for each of our reporting
units based on size, country and company specific risk premiums.  The market
approach compares the valuation multiples of similar companies to that of the
associated reporting unit.  In addition, we analyze differences between the sum
of the fair value of the reporting units and our total market capitalization for
reasonableness, taking into account certain factors including control premiums.

The fair value is then compared to its carrying value including goodwill. If the
fair value is in excess of its carrying value, the related goodwill is not
impaired. If the fair value is less than its carrying value, we recognize an
impairment charge in the amount that the carrying value exceeds the fair value
but not to exceed the carrying value of any goodwill.

We performed an interim review of goodwill assessment for our Latin America
reporting unit in the first quarter of 2019 and our annual goodwill assessment
as of October 1, 2019. As a result of these assessments we recorded non-cash
goodwill impairment charges of $126.6 million relating to our Canada reporting
unit, $80.8 million relating to our Domestic Environmental Solutions reporting
unit and $20.9 million relating to our Latin America reporting unit.

The factors considered in these goodwill impairment assessments are discussed
further above in the Goodwill Impairment section of Part II, Item 7.
Management's Discussion and Analysis of Financial Condition and Results of
Operations - Goodwill Impairment. (For additional information, see Part II, Item
8. Financial Statements and Supplementary Data; Note 7 - Goodwill and Other
Intangible Assets in the Consolidated Financial Statements).

A measure of sensitivity of the amount of goodwill impairment charges to key
assumptions is the amount by which each reporting unit's fair value exceeds
their respective carrying value. Subsequent to the impairment charges incurred
through December 31, 2019, the fair value exceeds the carrying value for all
reporting units, except Domestic Environmental Solutions, by no less than forty
percent.

We performed sensitivity analysis on our estimated fair values, noting that a 50
basis point increase in the discount rate or a 50 basis point reduction in the
long-term growth rate would not result in impairments for any of the reporting
units, except Domestic Environmental Solutions, which, would result in
incremental impairment charges of $39.0 million or $26.0 million, respectively.
Following the impairment charges recorded through December 31, 2019, the
Domestic CRS, Canada, and Latin America reporting units have no goodwill
remaining.

Intangible Assets Lives


2019 10-K Annual Report Stericycle, Inc. • 62


--------------------------------------------------------------------------------

PART II



We have determined that certain of our operating permits and certain tradenames
have indefinite lives due to our ability to renew them with minimal additional
cost, and therefore they are not amortized.

Our finite-lived intangible assets are amortized over their useful lives using
the straight-line method. Our customer relationships have useful lives from 10
to 25 years based upon the type of customer. We have non-compete covenant
intangibles with useful lives from 5 to 14 years. We also have tradename
intangibles with useful lives from 15 to 40 years.

We evaluate the useful life of our intangible assets annually to determine
whether events and circumstances warrant a revision to their remaining useful
life and changes are reflected prospectively as the intangible asset is
amortized over the revised remaining useful life.  In the fourth quarter of
2019, we performed the annual assessment of the useful life of our finite-lived
intangibles and made no changes to useful lives.

Assets and Liabilities Held-for-Sale



We classify Long-lived assets or disposal groups as held-for-sale when
management having the appropriate authority, generally our Board of Directors or
certain of our Executive Officers, commits to a plan of sale, the disposal group
is ready for immediate sale, an active program to locate a buyer has been
initiated and the sale is probable and expected to be completed within one
year. Once classified as held-for-sale disposal groups are valued at the lower
of their carrying amount or fair value less estimated selling costs. Where the
disposal group constitutes substantially all, generally more than 90% of the
assets and liabilities, of our operations in a foreign country the balance in
the cumulative currency translation adjustment, associated with that country is
included in the carrying value of the disposal group. If the carrying value,
including any amount associated with the cumulative currency translation
adjustment exceeds the fair value less estimated selling costs a held-for-sale
impairment charge is recorded to reduce the carrying value.

The estimate for fair value is reviewed at the end of every reporting period
that the disposal group is classified as held-for-sale and the carrying value
adjusted whenever the estimated fair value less costs to sell is less than the
carrying value.

Environmental Remediation Liabilities



Our environmental remediation liabilities primarily include costs associated
with remediating air, groundwater, surface water, soil contamination, and
applicable legal costs. To estimate our ultimate liability at these sites, we
evaluate several factors, including the nature and extent of contamination at
each identified site, the required remediation methods, timing of expenditures,
and the apportionment of responsibility among the potentially responsible
parties ("PRPs") and the financial viability of those PRP's. We routinely review
and evaluate sites that require remediation, considering whether we were an
owner, operator, transporter, or generator at the site, the amount and type of
waste hauled to the site and the number of years we contracted with or owned the
site. Next, we review the same information with respect to other named and
unnamed PRPs. Estimates of the cost for the likely remediation are then either
developed using our internal resources or by third party environmental engineers
or other service providers. (For additional information, see Part II, Item 8.
Financial Statements and Supplementary Data; Note 12 - Commitments and
Contingencies in the Consolidated Financial Statements).

Income Taxes



We record a provision for income taxes for the anticipated tax consequences of
our reported results of operations using the asset and liability
method. Deferred income taxes are recognized by applying enacted statutory tax
rates applicable to future years to differences between the financial statement



2019 10-K Annual Report Stericycle, Inc. • 63


--------------------------------------------------------------------------------

PART II



carrying amounts of existing assets and liabilities and their respective tax
basis as well as net operating loss and tax credit carryforwards. The effect on
deferred tax assets and liabilities of a change in tax rates is recognized in
income in the period that includes the enactment date. The measurement of
deferred tax assets is reduced, if necessary, by a valuation allowance for any
tax benefits for which future realization is uncertain.

Although we believe our assumptions, judgments and estimates are reasonable,
changes in tax laws or our interpretation of tax laws and the resolution of any
tax audits could significantly impact the amounts provided for income taxes in
our Consolidated Financial Statements.

In evaluating our ability to recover our deferred tax assets, in full or in
part, we consider all available positive and negative evidence, including our
past operating results, and our forecast of future earnings, future taxable
income and prudent and feasible tax planning strategies. The assumptions
utilized in determining future taxable income require significant judgment and
are consistent with the plans and estimates we are using to manage the
underlying businesses. Actual operating results in future years could differ
from our current assumptions, judgments and estimates. However, we believe that
it is more likely than not that most of the deferred tax assets recognized on
our Consolidated Balance Sheets will ultimately be realized. We record a
valuation allowance to reduce our deferred tax assets to the net amount that we
believe is more likely than not to be realized.

We did not recognize certain tax benefits from uncertain tax positions within
the provision for income taxes. We may recognize a tax benefit only if it is
more likely than not the tax position will be sustained on examination by the
taxing authorities, based on the technical merits of the position. The tax
benefits recognized in the financial statements from such positions are then
measured based on the largest benefit that has a greater than 50% likelihood of
being realized upon settlement. At December 31, 2019, our estimated gross
unrecognized tax benefits were $62.7 million, of which $61.3 million, if
recognized, would favorably impact our future earnings. Due to uncertainties in
any tax audit outcome, our estimates of the ultimate settlement of our
unrecognized tax positions may change and the actual tax benefits may differ
significantly from the estimates.

The Company filed a PFA with the IRS related to a claim under Internal Revenue
Code Section 1341 concerning the tax rate to be applied to the SQ Settlement on
the Company's 2018 tax return. The IRS has reviewed and has subsequently agreed
to hold discussions in 2020 regarding the PFA. Any positive income tax benefit
resulting from the claim in a future period will be recognized as appropriate in
accordance with the guidance in ASC 740 on the accounting for uncertain tax
positions. There can be no assurance that this amount or any amount will be
recovered as a result of this claim.

The Tax Act established global intangible low-taxed income ("GILTI") provisions
that impose a tax on foreign income in excess of a deemed return on intangible
assets of foreign corporations.  We recognize the taxes on GILTI as a period
expense rather than to recognize deferred taxes for basis differences that are
expected to affect the amount of GILTI inclusion upon reversal.

For further information see Part II, Item 8. Financial Statements and Supplementary Data; Note 10 - Income Taxes in the Consolidated Financial Statements.

Insured and Self-Insured Claims



The Company's insurance for workers' compensation, auto/fleet, general
liability, property and employee-related health care benefits is obtained using
high deductible insurance policies, if any, meaning that the Company has
retained a significant portion of the risks related to the claims associated
with these programs. The estimated exposure for unpaid claims and associated
expenses, including incurred but not reported losses, is based on a calculation
performed by a third party actuarial specialist using the



2019 10-K Annual Report Stericycle, Inc. • 64


--------------------------------------------------------------------------------

PART II



Company's historical claims experience. The accruals for these liabilities could
be revised if future occurrences or loss developments significantly differ from
the assumptions used. Estimated recoveries associated with insured claims are
recognized as assets when the receipt of such amounts is probable.

Stock-Based Compensation



We measure the cost of employee services received in exchange for an award of
equity instruments based on the grant-date fair value of the award. That cost is
recognized over the period during which an employee is required to provide
service in exchange for the award-the requisite service period, usually the
vesting period. Performance based awards are recognized consistent with
performance metrics and Accounting Standards Codification Section 718
Compensation - Stock Compensation. No compensation cost is recognized for equity
instruments for which employees do not render the requisite service.

The grant-date fair value of ISOs and similar instruments are estimated using
option-pricing models, (Black Scholes). The option pricing model includes
assumptions that are evaluated by a third-party valuation specialist and
evaluated and approved by the Vice President and Treasurer based on historical
experience, current company trends and comparative analysis to industry
trends. If an equity award is modified after the grant date, we assess the
impact of the modification and where necessary record compensation cost
calculated as any incremental fair value of the modified award over the fair
value of the original award immediately before the modification.

RSU's awarded to an employee and PSU's awarded are measured at fair value, once
the related performance criteria have been established. A non-vested equity
share unit awarded to an employee is measured at its fair value as if it were
vested and issued on the grant date.

For further detail, see Part II, Item 8. Financial Statements and Supplementary Data; Note 14 - Stock Based Compensation in the Consolidated Financial Statements.

© Edgar Online, source Glimpses